Linde PLC
LIN · NASDAQIndustrial Gases · Industrial Chemicals
Since the Report − 1.6%
Close on Report DayJul 31
$490.11▼ 5.9%Report-Day Move
- Market Cap(Today)
- ≈ $223 B
- 1Y Return(At Report)
- + 4%
- P/E($17.24 · Trailing 12M)
- 28.0
- PEG(company guidance 2026)
- 3.45
- Net Margin(Trailing 12M)
- 20.4%
Linde delivered record sales and record earnings and announced a record $11.1B project backlog, but its adjusted operating margin slipped 60 basis points versus a year ago. The stock fell roughly 6% on earnings day because the capital budget grew faster than profit and both the third-quarter and full-year EPS outlooks landed below market expectations. From here the question is what comes out of the strategic review of the U.S. home care business that is dragging the margin down.
Revenue (Q2)
$9.29B
▲ 9% YoY · Record
Adjusted EPS
$4.50
▲ 10% YoY · Record
Adjusted Operating Margin
29.5%
▼ 60 Bps (30.1% a Year Ago)
Project Backlog
$11.1B
Record Sale-of-Gas: $8.1B
Electronics Growth
18%
Fastest-Growing End Market
2026 Capex Guidance
$5.5-6.0B
▲ From $5.0-5.5B
Quarterly Revenue ($ Billion)
8.50
8.62
8.76
8.78
9.29
- Q2 25
- Q3 25
- Q4 25
- Q1 26
- Q2 26
- Annual Growth
- ▲ 9%Volume 2% · Price 2% · FX 2%
- Americas Share
- 44%$4.08B · ▲ 7% YoY
- Healthcare · US Home Care
- ~$30M margin hitUnder Strategic Review
Q3 2026 Company Guidance
- Q3 26 Adjusted EPS4.45 – 4.55 $
Midpoint $4.50 · Market Expectation $4.59Above the Range ▼
- Q3 26 EPS Growth6% – 8%
▲ 10% in Q2Slowing ▼
- FY26 Adjusted EPS17.7 – 17.9 $
Midpoint $17.80 · Market Expectation $17.93Above the Range ▼
- FY26 EPS Growth8% – 9%
Excluding FX · 1% FX tailwindIn Line With Algorithm ✓
- FY26 Capital Expenditure5.5 – 6.0 billion
Prior range $5.0-5.5BRevised Up ▲
The blue band is the company's low–high range; its length shows how much room the company left itself. The black triangle and the line beneath it mark where the market expected, and the notch in the band is the range's midpoint. The triangle appears only where a market expectation is known. Axis is ±16% around the midpoint.
- Capital Expenditure (Q2)
- $1.44B▲ 14% YoY
- Project Backlog
- $11.1BGas $8.1B · Plant $3.0B
- Returned to Shareholders (Q2)
- $1.59BDividends + Buybacks
“Linde employees delivered another solid quarter, generating record sales and EPS while maintaining industry-leading profitability with 29.5% operating margin and 23.5% return on capital.”
- record project backlog
- dissatisfaction with margin performance
- US home care strategic review
Summary
Linde reported the second quarter of 2026 before the open on July 31. Revenue reached $9.29 billion, up 9% from a year earlier and the highest quarterly sales in company history, while adjusted earnings per share rose 10% to $4.50 — also a record. Market Expectation sat between $4.49 and $4.53 a share, so the profit line landed essentially in line; the upside surprise came on revenue. The composition of that growth is what deserves attention: volume contributed just 2 points, price and mix 2 points, cost pass-through 1 point, currency 2 points and acquisitions 1 point. The adjusted operating margin came in at 29.5%, 60 basis points below the 30.1% of a year ago. Management lifted the bottom of its full-year outlook from $17.60 to $17.70, narrowing the range to $17.70-$17.90 a share.
Despite the records, the stock fell about 5.9% on the day to roughly $478.70, erasing some $14 billion of market value in a single session. No single number caused it; three of them arrived together. First, the margin: Linde's valuation premium rests on a habit of pushing the industry's best margin a little higher every quarter, and this quarter it moved the other way for the first time in a long while. Second, capital intensity: the 2026 capex plan was raised from $5.0-$5.5 billion to $5.5-$6.0 billion, roughly 9.5% higher, while the midpoint of the full-year profit outlook barely moved — investors read that as more cash out today for a payoff several years away. Third, Lincare: the U.S. home care business is carrying more than $30 million of quarterly margin pressure from cost inflation and reimbursement changes, and management said plainly that it is weighing strategic options for it.
We score the quarter 71 with a hold view. Why not higher: only 2 points of growth came from real volume, the margin is contracting, return on capital slipped to 23.5% and now sits below last year, and Lincare remains an open wound. Why not lower: the project backlog hit a record $11.1 billion, and the sale-of-gas portion jumped from $7.1 billion to $8.1 billion in a single quarter, almost entirely on one U.S. electronics award. That backlog takes two to three years to build and then ramp, so it contributes nothing to today's print. In short this is not a bad quarter — it is an expensive one. The company is buying its future, and the bill is being charged to today's margin and cash flow.
Full Review
ClaudeBeneath the record headline sits ordinary volume.
Read on its own, 9% revenue growth looks strong; broken into pieces it calms down considerably. Of the year-over-year gain, 2 points came from volume, 2 from price and mix, 1 from passing energy costs through to customers, 2 from currency and 1 from acquisitions. In other words, the amount of gas Linde actually sold rose just 2% from a year ago. The regional split tells the same story: the Americas grew 7% to $4.1 billion, Asia-Pacific 13% to $1.9 billion and EMEA 7% to $2.3 billion, and much of the fast Asian number came from equipment sales to electronics customers rather than underlying gas demand. Management repeated that its full-year outlook assumes no economic recovery at all. The one clear bright spot in manufacturing is aerospace, which by itself accounted for more than a third of manufacturing growth. Industrial gas demand is the real pulse of the economy, and that pulse is still beating slowly.
The margin story turned the wrong way.
The adjusted operating margin of 29.5% sits below last year's 30.1%, and even after stripping out the dilutive effect of cost pass-through there is roughly 30 basis points of genuine erosion. It has three sources. First, Lincare: the U.S. home care business is under more than $30 million of quarterly pressure from reimbursement changes and cost inflation, and management has changed leadership, begun pruning the portfolio and put strategic options on the table. Second, mix: equipment and hard goods sales to electronics customers are growing fast but carry lower margins than the gas business, so the faster they grow the more they drag the average down. Third, helium: Middle East supply disruptions distorted both pricing and cost, and management now sees normalization slipping into early 2027 with margin recovery spread over the next two to three quarters. Regionally, EMEA was the standout at a 35.7% margin; the Americas slipped 50 basis points to 31.2%, Asia-Pacific ran at 28.4% and Engineering at 16.0%. The level is still best in class — the problem is the direction, not the number.
Electronics and the AI backlog are the real story.
Electronics remained Linde's fastest-growing end market, up 18% year over year in the quarter, and the engine behind it is AI hardware. Advanced chip manufacturing consumes ultra-high-purity nitrogen, oxygen and argon continuously and at enormous scale, and those gases are delivered by pipeline from plants built next door to the fab — which means a customer won once becomes a decade-long contract. On the same day as earnings, Linde announced a $1 billion investment in Phoenix, Arizona: under a long-term agreement with one of the world's largest semiconductor manufacturers, two new SPECTRA air separation units will be added to the three already on site. Alongside it sits roughly $800 million of additional air separation and hydrogen capacity in Taiwan through Linde LienHwa, the company's joint venture there. That single award is the main reason the sale-of-gas backlog jumped from $7.1 billion to a record $8.1 billion; electronics now makes up about 22% of that backlog, roughly $1.78 billion. Adding the sale-of-plant side brings the total backlog to $11.1 billion. The thing for investors to hold in mind: this backlog takes two to three years to build and another year to reach full run rate, and it contributes nothing to the quarter just reported.
Capital intensity is rising while returns edge lower.
Quarterly capital expenditure rose 14% year over year to $1.44 billion, of which $780 million was project capital — a line that grew 27% on its own. The full-year capex plan was raised from $5.0-$5.5 billion to $5.5-$6.0 billion. At the same time, return on capital eased to 23.5%, below where it stood a year ago. The combination explains the share price reaction: Linde has for years been priced as a company that spends capital sparingly and converts every dollar of it into margin. Cash flow echoes the point — operating cash flow rose just 3% to $2.3 billion, far slower than investment. Shareholder returns were not cut in response: the company distributed $3.1 billion in the first half, $1.7 billion in buybacks and $1.4 billion in dividends. The question to track through the year is clean: will today's roughly $6 billion of spending push the margin back up in 2028-2029? If the answer is yes, this sell-off is an opportunity; if not, the valuation premium compresses into a permanently narrower band. Our cash flow guide and valuation guide are useful for reading that distinction.
Strengths
6- A record quarter: $9.29 billion of revenue and $4.50 of adjusted earnings per share, both the highest in company history.
- Project backlog hit a record $11.1 billion, with the sale-of-gas portion jumping from $7.1 billion to $8.1 billion in a single quarter.
- The electronics end market grew 18% year over year and now accounts for roughly 22% of the sale-of-gas backlog — demand tied directly to AI chip fabs.
- Long-term supply agreements worth $1 billion in Arizona and roughly $800 million in Taiwan; the on-site pipeline model delivers decade-long revenue visibility.
- A 29.5% adjusted operating margin and 23.5% return on capital remain among the best in the industry.
- The bottom of the full-year outlook was raised to a $17.70-$17.90 range, implying 8-9% growth.
Risks
6- The adjusted operating margin fell 60 basis points from a year ago, and Linde's valuation premium rests precisely on a steadily expanding margin.
- Volume growth was only 2%; much of the revenue gain came from price, currency and cost pass-through.
- Lincare, the U.S. home care business, is carrying more than $30 million of quarterly pressure and its strategic future is unresolved.
- The 2026 capex plan was lifted 9.5% while the midpoint of the profit outlook barely moved, putting free cash flow under pressure.
- Normalization of Middle East-driven helium supply problems has slipped to early 2027.
- Industrial demand in Europe and China is still weak; the outlook assumes no economic recovery at all, which limits the room for upside surprise.
What to Watch
6- Late October 2026 - third-quarter results. Company guidance calls for $4.45-$4.55 a share, or 6-8% growth from a year earlier.
- Second half of 2026 - more than 20 projects are scheduled to start up, representing roughly $1.3 billion of investment coming on stream.
- Coming quarters - the strategic review of Lincare continues; leadership has changed and portfolio pruning has begun, with a sale or separation decision possible within the year.
- Early 2027 - management's expected timing for helium market normalization, with margin recovery spread over the next two to three quarters.
- Late 2026 and beyond - construction timelines for the new air separation units in Phoenix, Arizona and in Taiwan, worth roughly $1.8 billion combined.
- February 2027 - fourth-quarter and full-year results plus the 2027 outlook; management says its 8-12% annual earnings growth algorithm holds even without an improving economy.
Upcoming Earnings
To Understand This